Chevron stock jumps on Trump’s Venezuela oil pivot; CVX eyes Jan. 30 earnings call

Chevron stock jumps on Trump’s Venezuela oil pivot; CVX eyes Jan. 30 earnings call

New York, January 5, 2026, 09:54 EST — Regular session

  • Chevron shares rose nearly 4% early Monday on headlines tied to U.S. moves in Venezuela.
  • Refiners and other energy names climbed as traders assessed potential changes to heavy-crude flows.
  • Investors now watch for policy details and Chevron’s Jan. 30 earnings call.

Chevron shares jumped on Monday after President Donald Trump said the United States would take control of Venezuela following the arrest of President Nicolas Maduro and that U.S. oil companies would help rebuild the country’s oil industry. The stock was up 3.8% at $161.87 in early trade, after touching $171.50 soon after the open. Trump said an embargo on Venezuelan oil exports would remain in place for now. 1

The headlines matter for Chevron because any shift in U.S. policy toward Venezuela would put a premium on speed and existing relationships. For producers, the upside is access to reserves and projects; for refiners, it is about feedstock.

Venezuelan crude is often described as “heavy sour” — thick and sulfur-rich — the kind of oil many U.S. Gulf Coast refineries were built to process. That linkage helps explain why the move spilled beyond drillers into refining names.

The rally was not confined to Chevron. Exxon Mobil was up 1.6% and ConocoPhillips rose 4.1%, while refiner Valero gained 9.2% in early trade. Wall Street opened higher more broadly, with the S&P 500 up about 0.5% at the bell. 2

Investors are still trying to separate tradable headlines from the operational grind of restoring output. Venezuela’s oil industry has suffered from years of sanctions and underinvestment, and any meaningful ramp would likely require time, capital and clearer rules.

“While the capture of Venezuelan president Maduro by American forces has dominated headlines, financial markets seem unperturbed,” Thomas Mathews of Capital Economics said in a report. Venezuela’s current oil output is about 1.1 million barrels a day, and some analysts expect it could rise sharply if investment returns, the report noted. 3

But the fast money risk is straightforward: the policy path may not match the market’s first reaction. With the embargo still in place, traders said the timeline for any change — and who benefits most — remains the key uncertainty.

The next test for the trade is whether Washington provides specifics on licenses, sanctions and oversight that would govern any corporate return. Refiners will also watch heavy-crude price spreads and product margins, which can swing quickly when supply assumptions shift.

Chevron said it will hold its fourth-quarter 2025 earnings conference call on Friday, January 30, at 11:00 a.m. ET, with CEO Mike Wirth and CFO Eimear Bonner scheduled to speak. The event could become a focal point for questions on Venezuela exposure, capital commitments and shareholder returns. 4

Until then, traders will track any formal U.S. steps on Venezuela policy and whether Chevron’s early spike can hold as the headline premium fades. The next clear catalyst for CVX is that January 30 earnings call.

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
AMD’s CES 2026 keynote is tonight: what Lisa Su’s AI message means for investors
Previous Story

AMD’s CES 2026 keynote is tonight: what Lisa Su’s AI message means for investors

GOLD stock steady after Gold.com closes Monex deal as gold price jumps on Venezuela tensions
Next Story

GOLD stock steady after Gold.com closes Monex deal as gold price jumps on Venezuela tensions

Go toTop